SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filings

Filing date Form Description Filing Group View
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
10-K/A

Amendment to a previously filed 10-K

Annual Filings
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML

Data provided by Kaleidoscope.